Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher I Bayly

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Bioorganic & Medicinal Chemistry Letters|September 13, 2005
Trifluoroethylamines as amide isosteres in inhibitors of cathepsin KW Cameron Black, Christopher I Bayly, Dana E Davis, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Nicotinyl aspartyl ketones as inhibitors of caspase-3Elise Isabel, W Cameron Black, Christopher I Bayly, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Structure based design of a series of potent and selective non peptidic PTP-1B inhibitorsCheuk K Lau, Christopher I Bayly, Jacques Yves Gauthier, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2005
Lipophilic versus hydrogen-bonding effect in P3 on potency and selectivity of valine aspartyl ketones as caspase 3 inhibitorsChristophe Mellon, Reneé Aspiotis, Cameron W Black, et al.
Journal of Medicinal Chemistry|February 3, 2006
Beta-substituted cyclohexanecarboxamide: a nonpeptidic framework for the design of potent inhibitors of cathepsin KSheldon N Crane, W Cameron Black, James T Palmer, et al.
Journal of Medicinal Chemistry|September 25, 2008
Identification of a nonbasic, nitrile-containing cathepsin K inhibitor (MK-1256) that is efficacious in a monkey model of osteoporosisJöel Robichaud, W Cameron Black, Michel Thérien, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Discovery of novel aspartyl ketone dipeptides as potent and selective caspase-3 inhibitorsYongxin Han, André Giroux, Erich L Grimm, et al.
Journal of Chemical Theory and Computation|April 21, 2026
Developing and Benchmarking Sage 2.3.0 with the AshGC Neural Network Charge ModelLily Wang, Irfan Alibay, Pavan Kumar Behara, et al.
Journal of Chemical Theory and Computation|September 22, 2021
Development and Benchmarking of Open Force Field v1.0.0-the Parsley Small-Molecule Force FieldYudong Qiu, Daniel G A Smith, Simon Boothroyd, et al.
Journal of Chemical Theory and Computation|May 11, 2023
Development and Benchmarking of Open Force Field 2.0.0: The Sage Small Molecule Force FieldSimon Boothroyd, Pavan Kumar Behara, Owen C Madin, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Bioorganic & Medicinal Chemistry Letters|September 13, 2005
Trifluoroethylamines as amide isosteres in inhibitors of cathepsin KW Cameron Black, Christopher I Bayly, Dana E Davis, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Nicotinyl aspartyl ketones as inhibitors of caspase-3Elise Isabel, W Cameron Black, Christopher I Bayly, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Structure based design of a series of potent and selective non peptidic PTP-1B inhibitorsCheuk K Lau, Christopher I Bayly, Jacques Yves Gauthier, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2005
Lipophilic versus hydrogen-bonding effect in P3 on potency and selectivity of valine aspartyl ketones as caspase 3 inhibitorsChristophe Mellon, Reneé Aspiotis, Cameron W Black, et al.
Journal of Medicinal Chemistry|February 3, 2006
Beta-substituted cyclohexanecarboxamide: a nonpeptidic framework for the design of potent inhibitors of cathepsin KSheldon N Crane, W Cameron Black, James T Palmer, et al.
Journal of Medicinal Chemistry|September 25, 2008
Identification of a nonbasic, nitrile-containing cathepsin K inhibitor (MK-1256) that is efficacious in a monkey model of osteoporosisJöel Robichaud, W Cameron Black, Michel Thérien, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Discovery of novel aspartyl ketone dipeptides as potent and selective caspase-3 inhibitorsYongxin Han, André Giroux, Erich L Grimm, et al.
Journal of Chemical Theory and Computation|April 21, 2026
Developing and Benchmarking Sage 2.3.0 with the AshGC Neural Network Charge ModelLily Wang, Irfan Alibay, Pavan Kumar Behara, et al.
Journal of Chemical Theory and Computation|September 22, 2021
Development and Benchmarking of Open Force Field v1.0.0-the Parsley Small-Molecule Force FieldYudong Qiu, Daniel G A Smith, Simon Boothroyd, et al.
Journal of Chemical Theory and Computation|May 11, 2023
Development and Benchmarking of Open Force Field 2.0.0: The Sage Small Molecule Force FieldSimon Boothroyd, Pavan Kumar Behara, Owen C Madin, et al.
Pageof 4